Podcast

Management of Heart Failure with Normal EF: A Geriatric Disease?

Presented at the 6th Annual Dartmouth Conference on Advances in Heart Failure at the Dartmouth Hitchcock Medical Center, Lebanon, N.H.

Mathew S. Maurer, MD, director, Clinical Cardiovascular Research Laboratory for the Elderly, Columbia University Medical Center, New York, discusses “Management of Heart Failure with Normal EF: A Geriatric Disease?” Presented at the 6th Annual Dartmouth Conference on Advances in Heart Failure, held Monday, May 24, 2010, at the Dartmouth Hitchcock Medical Center, Lebanon, N.H.

Click here to access this third-party resource.

Related Videos
What is the Global Lung Function Initiative and Its Purpose for Lung Function Testing?
Greg A. Sachs, MD I Credit: Regenstrief Institute
Advocating for Race-Neutral Approach to Pulmonary Function Testing with Meredith McCormack, MD, and Loretta Que, MD
Skin of Color Savvy: The Art and Science of Treating Patients of Color
Looking at This Year in Pulmonology: A Lungcast 2024 Recap
Experts' Perspectives: Top Stories in Cardiology for 2024
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management | Image Credit: Emory University
Related Content
Lovedeep Singh Dhingra, MBBS, a postdoctoral fellow in the CarDS Lab, Yale
February 4th 2025

New AI Tool Identifies Risk of Future Heart Failure

Julia Eisen
Skin of Color Savvy: Pigmentary Disorders in Skin of Color, with Nada Elbuluk, MD, and Michelle Rodrigues, MBBS
February 3rd 2025

Skin of Color Savvy: Pigmentary Disorders in Skin of Color, with Nada Elbuluk, MD, MSc, and Michelle Rodrigues, MBBS

Rachel Lampert, MD, Robert W Berliner Professor of Medicine in the Section of Cardiovascular Medicine at Yale School of Medicine
February 4th 2025

Ablation May Be Better Choice for Athletes with Atrial Fibrillation

Stacy Kish
Diabetes Dialogue: Understanding Semaglutide (Ozempic) in CKD and T2D
January 31st 2025

Diabetes Dialogue: Understanding Semaglutide (Ozempic) in CKD and T2D

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Mulubrhan Mogos, PhD, MSc I Credit: Vanderbilt University
February 4th 2025

Propranolol Linked to Lower Ischemic Stroke Risk in Females with Migraine

Chelsie Derman
Bulk Ordering Boosts Lipid Screening Uptake Versus Usual Care | Image Credit: LinkedIn
February 3rd 2025

Bulk Ordering Boosts Lipid Screening Uptake Versus Usual Care

Connor Iapoce
© 2025 MJH Life Sciences

All rights reserved.